Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antihistamine study

This article was originally published in The Tan Sheet

Executive Summary

The Transportation Secretary "shall review available information on the effects of medications (including antihistamines) on driver fatigue, awareness and performance and shall consider encouraging, if appropriate, the use of nonsedating medications (including nonsedating antihistamines) as a means of reducing the adverse effects of the use of other medications by drivers," under the conference report to the transportation bill (105-555) passed by the House and Senate May 22 and signed into law (105-178) June 9. The measure potentially could benefit Claritin (loratidine) manufacturer Schering-Plough, which is understood to have backed the provision...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088524

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel